Tuberculosis (BCG) Vaccine Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Phase Ⅱ Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
Condition: Tuberculosis Interventions: Biological: Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02); Biological: High-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02); Biological: High-dose adjuvant for freeze-dried recombinant tuberculosis vaccine (AEC / BC02); Biological: Lyophilized recom binant tuberculosis vaccine (AEC / BC02) placebo Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2022 Category: Research Source Type: clinical trials
